Regent Peak Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Regent Peak Wealth Advisors's BMY Position: Q1 2024 in Review
Regent Peak Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 6,278 shares — an estimated $322K sold.
Regent Peak Wealth Advisors first reported a position in BMY in Q4 2019 and held it in 17 quarters. The position peaked at $2.4M in Q1 2023. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Regent Peak Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- Regent Peak Wealth Advisors sold 6,278 Bristol-Myers Squibb shares in Q1 2024, an estimated $322K.
- Regent Peak Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 17 quarters.
- Regent Peak Wealth Advisors's Bristol-Myers Squibb position peaked at $2.4M in Q1 2023.
- 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Regent Peak Wealth Advisors's 13F filing for Q1 2024, filed 1 May 2024.